{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:56:05Z","timestamp":1759938965700},"reference-count":25,"publisher":"American Diabetes Association","issue":"11","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:p>OBJECTIVE\u2014 To evaluate the relation between cardiovascular disease (CVD) risk factors and hormone therapy, serum hormone levels, glucose tolerance, and psychosocial and psychological conditions in subjectively healthy obese female subjects.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014 The study included 606 women, aged 50\u201364 years, with BMI 30\u201340 kg\/m2 and no history of cardiovascular or other severe diseases. One group with a CVD risk profile (n = 473) (i.e., cholesterol &amp;gt;7.0 mmol\/l, HDL cholesterol &amp;lt;1.2 mmol\/l, triglycerides &amp;gt;2.0 mmol\/l, systolic or diastolic blood pressure &amp;gt;140\/90 mmHg, or waist-to-hip ratio &amp;gt;0.85) was compared with women without such risk (n = 133). Steroid hormones, leptin, insulin, and oral glucose tolerance tests (OGTTs) were analyzed. A subgroup of women with baseline impaired glucose tolerance (IGT) completed a 2.5-year follow-up OGTT.<\/jats:p>\n               <jats:p>RESULTS\u2014 Fewer obese postmenopausal women with CVD risk had ever used hormone therapy (odds ratio 0.24 [95% CI 0.07\u20130.75]), after multivariate adjustments. Furthermore, women with CVD risk had a higher testosterone index (1.07 [1.01\u20131.13]) and more had insulin resistance (1.04 [1.00\u20131.08]) and IGT (2.92 [1.50\u20135.69]), while OGTT was similar at follow-up. No differences were observed regarding family history or lifestyle, except that fewer women with CVD risk consumed fruits, boiled vegetables, or whole-grain cereals. More women with CVD risk lived alone (3.26 [1.28\u20138.31]) and had more mental problems (1.16 [1.05\u20131.28]).<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014 Previously healthy obese women with a CVD risk profile seemed to have a high risk of diabetes, as well as psychosocial or psychological problems. Hormone therapy was associated with reduced CVD risk. Obesity\u2019s growing burden on society makes it more important to further target individuals that are at greatest risk of future health hazards.<\/jats:p>","DOI":"10.2337\/dc06-1262","type":"journal-article","created":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T00:35:50Z","timestamp":1161822950000},"page":"2477-2482","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":4,"title":["Obese Women and the Relation Between Cardiovascular Risk Profile and Hormone Therapy, Glucose Tolerance, and Psychosocial Conditions"],"prefix":"10.2337","volume":"29","author":[{"given":"Jonas","family":"Lidfeldt","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Lund University, Malmo\u0308, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go\u0308ran","family":"Samsioe","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl-David","family":"Agardh","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Lund University, Malmo\u0308, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031216515068400_R1","doi-asserted-by":"crossref","unstructured":"Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999\u20132002. JAMA\u2008291: 2847\u20132850, 2004","DOI":"10.1001\/jama.291.23.2847"},{"key":"2022031216515068400_R2","doi-asserted-by":"crossref","unstructured":"Eiben G, Dey DK, Rothenberg E, Steen B, Bjo\u0308rkelund C, Bengtsson C, Lissner L: Obesity in 70-year-old Swedes: secular changes over 30 years. Int J Obes\u200829:810\u2013817, 2005","DOI":"10.1038\/sj.ijo.0802940"},{"key":"2022031216515068400_R3","unstructured":"World Health Organization: Obesity: Preventing and Managing the Global Epidemic. Geneva, World Health Org., 2000 (Tech. rep. no. 894)"},{"key":"2022031216515068400_R4","unstructured":"National Institute of Health: The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD, National Institutes of Health, 2000 (Publ. no. 00-4084)"},{"key":"2022031216515068400_R5","doi-asserted-by":"crossref","unstructured":"Anderson DA, Wadden TA: Treating the obese patient: suggestions for primary care practice. Arch Fam Med\u20088:156\u2013167, 1999","DOI":"10.1001\/archfami.8.2.156"},{"key":"2022031216515068400_R6","doi-asserted-by":"crossref","unstructured":"Sjostrom L, Lindroos AK, Peltonen M, the Swedish Obese Subjects Study Scientific Group: Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med\u2008351:2683\u20132693, 2004","DOI":"10.1056\/NEJMoa035622"},{"key":"2022031216515068400_R7","unstructured":"National Task Force on the Prevention and Treatment of Obesity: Medical care for obese patients: advice for health care professionals. Am Fam Physician\u200865:81\u201388, 2002"},{"key":"2022031216515068400_R8","doi-asserted-by":"crossref","unstructured":"Villareal DT, Banks M, Siener C, Sinacore DR, Klein S: Physical frailty and body composition in obese elderly men and women. Obes Res\u200812:913\u2013920, 2004","DOI":"10.1038\/oby.2004.111"},{"key":"2022031216515068400_R9","doi-asserted-by":"crossref","unstructured":"Lidfeldt J, Nyberg P, Nerbrand C, O\u0308jehagen A, Samsioe G, Scherste\u0301n B, Agardh C-D: Biolgical factors are more important than socio-demographic and psychosocial conditions in relation to hypertension in middle-aged women: the Women\u2019s Health In the Lund Area (WHILA) Study. Blood Press\u200811:270\u2013278, 2002","DOI":"10.1080\/080370502320779476"},{"key":"2022031216515068400_R10","unstructured":"Lidfeldt J, Nerbrand C, Samsioe, G, Scherste\u0301n B, Agardh C-D: A screening procedure detecting high-yield candidates for OGTT: the Women\u2019s Health In the Lund Area (WHILA) Study: a population based study of middle-aged Swedish women. Eur J Epidemiol\u200817:943\u2013951, 2001"},{"key":"2022031216515068400_R11","doi-asserted-by":"crossref","unstructured":"Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Scherste\u0301n B, Agardh C-D: Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome: the Women\u2019s Health In the Lund Area (WHILA) Study. Diabetes Obes Metab\u20085:106\u2013112, 2003","DOI":"10.1046\/j.1463-1326.2003.00250.x"},{"key":"2022031216515068400_R12","doi-asserted-by":"crossref","unstructured":"Lidfeldt J, Nerbrand C, Samsioe G, Agardh C-D: Women living alone have an increased risk to develop diabetes, which is explained mainly by lifestyle factors. Diabetes Care\u200828:2531\u20132536, 2005","DOI":"10.2337\/diacare.28.10.2531"},{"key":"2022031216515068400_R13","unstructured":"Tchernof A, Poehlman ET, Despres JP: Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab\u200826:12\u201320, 2000"},{"key":"2022031216515068400_R14","doi-asserted-by":"crossref","unstructured":"Roux L, Donaldson C: Economics and obesity: costing the problem or evaluating solutions? Obes Res\u200812:173\u2013179, 2004","DOI":"10.1038\/oby.2004.23"},{"key":"2022031216515068400_R15","unstructured":"Asp NG, Isaksson A\u030a, Johansson U, Ja\u0308gerstad M, Lanke J, Mattisson I, Svederberg E, Scherste\u0301n B: Dietary habits among adults in Olofstro\u0308m: a baseline study. Scand J Nutr\u200836:106\u2013114, 1992"},{"key":"2022031216515068400_R16","doi-asserted-by":"crossref","unstructured":"Shelley JM, Green A, Smith AM, Dudley E, Dennerstein L, Hopper J, Burger H: Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann Epidemiol\u20088:39\u201345, 1998","DOI":"10.1016\/S1047-2797(97)00123-3"},{"key":"2022031216515068400_R17","doi-asserted-by":"crossref","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia\u200828:412\u2013419, 1985","DOI":"10.1007\/BF00280883"},{"key":"2022031216515068400_R18","doi-asserted-by":"crossref","unstructured":"Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice: European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J\u200824:1601\u20131610, 2003","DOI":"10.1016\/S0195-668X(03)00347-6"},{"key":"2022031216515068400_R19","unstructured":"Tibblin G, Tibblin B, Peciva S, Kullman S, Sva\u0308rdsudd K: \u201cThe Goteborg quality of life instrument\u201d: an assessment of well-being and symptoms among men born 1913 and 1923: methods and validity. Scand J Prim Health Care\u20081:33\u201338, 1990"},{"key":"2022031216515068400_R20","doi-asserted-by":"crossref","unstructured":"Li TY, Rana JS, Manson JE, Willett WC, Stmpfer MJ, Colditz GA, Rexrode KM, Hu FB: Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation\u2008113:499\u2013506, 2006","DOI":"10.1161\/CIRCULATIONAHA.105.574087"},{"key":"2022031216515068400_R21","doi-asserted-by":"crossref","unstructured":"Grodstein F, Manson JE, Stampfer MJ: Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health\u200815:35\u201344, 2006","DOI":"10.1089\/jwh.2006.15.35"},{"key":"2022031216515068400_R22","doi-asserted-by":"crossref","unstructured":"Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R: Conjugated equine estrogens and coronary heart disease: the Women\u2019s Health Initiative. Arch Intern Med\u2008166:357\u2013365, 2006","DOI":"10.1097\/01.ogx.0000219472.72978.7a"},{"key":"2022031216515068400_R23","doi-asserted-by":"crossref","unstructured":"Mayes JS, Watson GH: Direct effects of steroid hormones on adipose tissues and obesity. Obesity Rev\u20085:197\u2013216, 2004","DOI":"10.1111\/j.1467-789X.2004.00152.x"},{"key":"2022031216515068400_R24","doi-asserted-by":"crossref","unstructured":"Diamond MP, Grainger D, Diamond MC, Sherwin RS, Defronzo RA: Effects of methyltestosterone on insulin secretion and sensitivity in women. J Clin Endocrinol Metab\u200883:4420\u20134425, 1998","DOI":"10.1210\/jc.83.12.4420"},{"key":"2022031216515068400_R25","doi-asserted-by":"crossref","unstructured":"Fontaine KR, Barofsky I: Obesity and health-related quality of life. Obesity Rev\u20082:173\u2013182, 2001","DOI":"10.1046\/j.1467-789x.2001.00032.x"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/11\/2477\/666232\/zdc01106002477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/11\/2477\/666232\/zdc01106002477.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T17:29:17Z","timestamp":1647106157000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/29\/11\/2477\/24566\/Obese-Women-and-the-Relation-Between"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc06-1262","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}